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1.  Scales 
 
1.1. modified Rankin Scale (mRS) 
 
mRS 0 no symptoms at all 
mRS 1 no significant disability despite symptoms; able to carry out all 
usual duties and activities 
mRS 2 slight disability; unable to carry out all previous activities, but 
able to look after own affairs 
mRS 3 moderate disability; requiring some help, but able to walk 
without assistance 
mRS 4 moderately severe disability; unable to walk without assistance 
and unable to attend to own bodily needs without assistance 
mRS 5 severe disability; bedridden, incontinent and requiring constant 
nursing care and attention 
mRS 6 death 
 
 
1.2. Hunt & Hess (HH) 
 
HH 1  asymptomatic or minimal headache and slight neck stiffness 
HH 2  moderate to severe headache; neck stiffness; no neurologic 
deficit except cranial nerve palsy 
HH 3  drowsy; minimal neurologic deficit 
HH 4  stuporous; moderate to severe hemiparesis; possibly early 
decerebrate rigidity and vegetative disturbances 
HH 5  deep coma; decerebrate rigidity; moribund 
 
 
1.3. Fisher Grade: appareance of SAH on CT scan 
 
Fisher I no hemorrhage evident 
Fisher II subarachnoid hemorrhage less than 1 mm thick 
Fisher III subarachnoid hemorrhage more than 1 mm thick 
Fisher IV intraventricular hemorrhage or parenchymal extension 
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2. Introduction 
Coil occlusion of intracranial aneurysms, both ruptured and unruptured, is 
safe and efficacious if patient selection and endovascular treatment are 
carried out adequately (Raymond et al. 1997, Roy et al. 2001, Pierot et al. 
2008, Spetzler et al. 2013). A major limitation for this treatment modality is 
related to the geometry of the target aneurysm. A neck of ≥ 4 mm and a 
fundus width/neck ratio ≤ 1 mm are unfavorable for simple coiling (Brinjikji et 
al. 2009). Intraluminal flow diversion has solved this issue for sidewall 
aneurysms (Fischer et al. 2011). Intraaneurysmal flow disrupter (e.g., WEB, 
Sequent Medical; LUNA, nFocus/Covidien) are promising but not yet fully 
established devices for selected bifurcation aneurysms (Klisch et al. 2011, 
Pierot et al. 2012, Lubicz et al. 2013, Pierot et al. 2013). For WNBAs, the 
techniques to assist coil occlusion include single or crossing stent 
deployment and balloon remodeling (Lubicz et al. 2009, Moret et al. 1997), 
both requiring catheter access to at least one efferent vessel of the 
bifurcation. This catheterization can sometimes be difficult. Coil assist 
techniques without efferent vessel access include TriSpan device (Raymond 
et al. 2001), which is no longer available, and the deployment of self-
expanding stents with their distal end inside the aneurysm, the so-called 
“waffle cone” technique (Horowitz et al. 2006). The stents used for the 
“waffle cone” technique (e.g., Solitaire AB, Covidien; Enterprise, Codman) 
are not optimized for this purpose and are far from ideal.  
pCONus
®
 (phenox) is a dedicated neurovascular device, which was 
designed to address the functional needs of an extra-intrasaccular neck 
bridging aneurysm implant to assist the coil occlusion of WNBAs. 
The present thesis summarizes the in vitro study of the device, its initial use 
in 9 New Zealand White Rabbits as well as the angiographic and clinical 
results in the endovascular treatment of 50 intracranial aneurysms. In the 
clinical use of pCONus
®
 we refer to the initial state of the patient, the 
angiographic outcome of the treatment session, possible complications and 
clinical outcome after the treatment. The results of the follow-up, the 
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necessity and, if necessary, subsequent treatments, and in turn, their clinical 
outcome are presented elsewhere. 
 
3. Device description 
The pCONus
®
 (phenox GmbH, Bochum, Germany) was developed as an 
endovascular implant for the bridging of intracranial WNBAs to enable 
aneurysm coiling.  
pCONus
®
 is a stent-like lasercut vessel implant made of Nitinol with 4 loops 
(petals) at its distal end, which are flared in the radial direction (Figure 1).  
The distal inner diameter of the pCONus
®
 is additionally crossed by 6 nylon 
fibers creating a mechanical barrier between the aneurysm and the parent 
vessel (Figure 2). The biocompatibility of these fibers is certified and the 
same material was used for coils with attached nylon fibers (ev3).   
The proximal end of the pCONus
®
 implant as well as the 4 distal loops carry 
segmental radiopaque markers made of Platinum-Iridium wire. They allow 
visual control of the otherwise none radiopaque device under fluoroscopy. 
pCONus
® 
ends proximally in one eccentric strut, which carries a detachment 
element connected to an insertion wire made of stainless steel. This 
insertion wire is 180 cm long, has a diameter of 0.42 mm (0.0165 inch) and 
is conically shaped at its distal end. A 30 mm long radiopaque marker made 
of Platinum-Iridium wire at the distal tip of the insertion wire allows alignment 
with the two markers of the delivery microcatheter. The detachment element 
consists of a Cobalt Chromium wire, which can be dissolved electrolytically 
by direct electric current using available coil detachment generator devices.  
The distal diameters of the expanded petals are available in 5, 6, 8, 10, 12 
and 15 mm. The stent-like shaft has a 4 mm diameter and is 20 or 25 mm 
long (Table 1). This product range allows the implantation into target vessels 
with a diameter between 2.5 and 3.75 mm, covering aneurysm necks of 4 to 
14 mm diameter.  
The radial force of the device is in between the radial forces of other 
intracranial stents like Solitaire AB (ev3/Covidien) or Neuroform (Stryker).  
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pCONus
®
 is compatible with standard microcatheters with an inner diameter 
of 0.021” or 0.027” (e.g., RapidTransit, Codman Neurovascular; Marksman, 
Covidien). We always used 0.021” microcatheters for easier access.  
The device allows controlled insertion, deployment and eventual withdraw 
into the microcatheter. The radiopacity is sufficient for a visual control of 
deployment under high quality fluoroscopy but does not impair the 
visualization of the device using flat panel detector CT (e.g., DynaCT, 
Siemens; XperCT, Philips). 
Figure 1: (A) The pCONus
®
 is a self-expanding, completely retrievable, 
electrolytically detachable device with a proximal shaft (similar to stents) and 4 
distal petals at its distal end. The proximal end (yellow asterisk) as well as the 4 
distal petals (red asterisks) contain radiopaque markers. (B) Similar to the waffle 
cone technique, the 4 distal loops of the pCONus
®
 are deployed inside the 
aneurysm at the level of the neck (red arrow), assisting coil occlusion. The proximal 
detachment element consists of a Cobalt Chromium wire, which can be dissolved 
electrolytically (yellow arrow). 
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Figure 2:  Six Nylon fibers cross the distal inner diameter of the pCONus
®
 (red 
dashed lines), creating a mechanical barrier between the aneurysm and the parent 
vessel, and preventing coil protrusion into the shaft of the device. 
                       
 
 
 
 
Table 1:  Available pCONus
®
 sizes. 
pCONus® Stent-shaft diameter Stent-shaft length Petals diameter 
                                                                                                  
                                                                                           
                                              
4 mm 
20 mm
5 mm
6 mm
8 mm 
                                           
25 mm 
10 mm 
12 mm 
15 mm 
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4. Animal experiments 
As a part of the design validation process of the device an in vivo study was 
conducted using New Zealand White Rabbits with microsurgically created 
common carotid artery wide neck bifurcation aneurysms between August 
2011 and April 2012.  
The study was conducted in the animal laboratories of the “Allgemeines 
Krankenhaus der Stadt Wien”, Medical University of Vienna, Austria, in 
cooperation with PD Dr. Camillo Sherif, neurosurgeon at “Krankenanstalt 
Rudolfstiftung”, Vienna, and managing partner NVtec Neurovascular 
Technologies GmbH, Vienna, and member of the Cerebrovascular Research 
Group at the Department of Biomedical Research at the Medical University 
of Vienna. These animal experiments were registered under the number 
66.009/0215-II/10b/2008. 
The purpose of this in vivo study was to assess the acute therapeutic 
success and chronic functional success of the pCONus
®
 for the treatment of 
bifurcation aneurysms as support for coiling procedures.  
At the end of the follow-up period the aneurysms were explanted for 
complete histological and pathological analysis in order to evaluate the 
biocompatibility and hemocompatibility of the device. 
 
 
4.1. Animal aneurysm preparation 
Wide-neck aneurysms (n = 9) were created according the procedures 
published by Sherif et al. and Marbacher et al. using New Zealand White 
Rabbits (Sherif et al. 2011, Marbacher et al. 2011). 
The aneurysm pouch was made using a 1 cm long segment of the external 
jugular vein, which was cut longitudinally (1), folded along its transverse axis 
(2) and sutured at proximal and distal ends (3). After that this pocket was 
sutured to the artificial bifurcation of both common carotid arteries (Figure 3 
and 4).   
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Figure 3:  Creation of the aneurysm pouch in rabbits. 
 
            
 
 
Figure 4: (A) Photograph during the operation. (B) Aneurysm visualized by MR 
angiography. 
 
 
 
4.2 . Aneurysm embolization and ongoing animal care 
At least 3 weeks passed between aneurysm creation and embolization. The 
animal received 10 mg/kg of acetylsalicylic acid and clopidogrel at least 3 
days before the treatment. Anesthesia was induced by using 50 mg/kg of 
ketamine, 2 mg/kg xylazine, and 1.2% isofluran, and was maintained by 
using ketamine and xylazine via perfusor with ECG and SiO2 monitoring. 
A surgical cut-down of the right femoral artery was performed, and a 4F 
sheath was inserted. A 4F guide catheter (Tempo4; Cordis) was placed into 
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the carotid artery just proximal to the target aneurysm. Heparin (100 U IV) 
was administered, and then a microcatheter (Prowler Select Plus; Codman 
Neurovascular) was placed over a microguidewire (Traxcess14; 
MicroVention Terumo) inside the aneurysm, about 3 mm distal to the 
aneurysm neck in order to insure the desired placement position of the 
pCONus
®
. 
The pCONus
® 
size was selected to match the aneurysm neck with a 
pCONus
® 
plate diameter that had nearly the same neck size. The wire was 
removed, and the pCONus
® 
device was advanced into the aneurysm cavity 
and deployed. After a DSA the pCONus
® 
was electrolytically detached. 
Thereafter the pCONus
® 
was carefully passed with a second microcatheter, 
placing the tip inside the aneurysm, about 3 mm distal of the aneurysm neck. 
After coiling, the microcatheter was removed and a DSA of the common 
carotid artery was performed (Figure 5).  
The sheath was removed and the femoral artery was ligated over the site to 
obtain hemostasis. The incision in the groin was closed with sutures. At this 
point the anesthesia was discontinued and the animal was returned to its 
pen. 
Postmedication included antiplatelet therapy with 10 mg/kg of acetylsalicylic 
acid and clopidogrel per os. 
 
 
4.3. Angiographic evaluation  
All animals were followed for a nominal period of 3 months or longer. This 
period is the target endpoint and subject to minor duration fluctuations based 
on the availability of the animal laboratory facility. At this point, the 
aneurysms were evaluated angiographically. The follow-up angiography was 
performed with a sheath in the ear vein. 
Aneurysm dimensions (neck width, aneurysmal height and width) were 
determined with DSA measurements, which were adjusted by using an 
external sizing device of known diameter. Angiographic evaluation was 
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performed by angiographic analysis conducted immediately after device 
implantation as well as prior to euthanasia. 
The degree of aneurysm occlusion was assessed by using the 3-point 
Raymond scale (Raymond et al. 2003): grade 1: complete occlusion; grade 
2: neck remnant; grade 3: incomplete occlusion.  
Interval changes were registered by comparing the 3-point occlusion scale 
results of individual aneurysms immediately after implantation with a 
separate 3-point scale indicating that the aneurysm was stable, recanalized, 
or progressively thrombosed. 
 
Figure 5: Animal No. 31: (A) Vessels with aneurysm before implantation. (B) 
Implant and coils directly after implantation. (C) Final DSA before termination. 
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4.4. Euthanasia 
At the time of sacrifice, animals were deeply anesthetized. Animals were 
then humanely euthanized with a lethal injection of pentobarbital. Harvested 
aneurysms with implant and sufficient artery length distal and proximal to the 
implant were immediately covered with a 5% formalin solution. 
Explanted aneurysms were forwarded to the appropriate laboratory for 
evaluation. 
 
4.5. Conventional histopathological processing 
The histopathologic study was performed in the “Labor für medizinische 
Materialprüfung GmbH”, technological medical center of Aachen, Germany, 
in order to evaluate the biocompatibility of the device.  
Various sections from the distal and proximal part of delivered test items of 
each specimen without implant were placed in HistoTec
®
 boxes. Parts with 
implants were prepared for polymer embedding (Figure 6). 
Tissue samples with implants were dehydrated in alcohol and embedded in 
plastic Technovit 7200 VLC. After the steps of polymerization the specimens 
were placed in an incubator at 50 degrees Centigrade for up to 12 hours to 
complete the polymerization. After that several sections of the specimens 
were grinded and stained with hematoxylin and eosin (H&E) (Figure 7). 
The explanted aneurysms were reviewed for any protrusions into the parent 
vessel as well as thrombus formation, recanalization, intimal hyperplasia, 
elastic lamina disruption, foreign body giant cell reaction, and signs of 
inflammation. 
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Figure 6: Photographic documentation of the sample P0384-09/12 (left). 
Photographic documentation of the sample P0384-09/12 after embedding with 
marked grinding surface (right). 
 
 
 
Figure 7: Microscopic documentation of the sample P0384-09/12 with implant, 
grinding surface detachment element; magnifications x 40, x 100, x 200, x 400 
(H&E). 
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4.6. Angiographic and technical results 
In the course of this in vivo study 9 New Zealand White Rabbits with venous 
pouch aneurysms were treated with a pCONus
®
 implant to enable 
subsequent coiling. 
In all these cases, handling and behavior of the pCONus
®
 implant was within 
expectation. The self-expansion, deployment and detachment functioned 
very well. The implants did not migrate inside the target vessel and did not 
cause perforation, ruptures or vessel diameter changes. 
The implant could be easily passed by the coil delivery microcatheter. 
Structural and material damages of the implant could not be observed. 
One coiling procedure ended up with minor vasospasm that was medically 
treated and is a common reaction of vessels after excessive mechanical 
manipulation.  
At the end of the procedure (Table 2), complete occlusion (grade 1) was 
achieved in 5/9 aneurysms (55.6%). 2/9 aneurysms (22.2%) were graded as 
neck remnant (grade 2) and another 2 aneurysms (22.2%) as incompletely 
occlusion (grade 3). 
 
Table 2: Initial angiographic results after pCONus® assisted coiling in 9 rabbits with 
venous pouch aneurysms using the 3-point scale. 
Occlusion rates  n % 
1 – complete occlusion 5 55.6 
2 – neck remnant 2 22.2 
3 – incomplete occlusion 2 22.2 
 
 
 
Five animals (55.5%) were terminated after a period of 3.4 to 11.5 months 
and demonstrated that the treated aneurysms were very well occluded. Four 
animals (44.4%) died before the end of the study due to various reasons: 
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 stroke in another artery after extended anaesthesia duration (n = 1), 
one day after embolization treatment 
 extended anaesthesia duration (n = 1), on same day of embolization 
treatment 
  urinary hemorrhage due to excessive antiplatelet effects (n = 1), 21 
days after embolization treatment 
 unknown reasons (n = 1), 1.5 months after embolization treatment. 
Autopsy did not show any device related reason. 
 
 
From the 5 cases with follow-up (Table 3), one aneurysm presented coil 
compaction (20%) and two (40%) minor neck remnants after the coiling 
procedures, which would have required additional coiling treatments.  
 
Table 3: Angiographic follow-up results after pCONus® assisted coiling in 5 out of 9 
rabbits with venous pouch aneurysms using the 3-point scale. 
Occlusion rates  n % 
1 – complete occlusion 2 40 
2 – neck remnant 2 40 
3 – incomplete occlusion 1 20 
 
 
 
The most important criteria and results of the in vivo tests are summarized in 
table 4. 
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Table 4: Criteria and results of 9 New Zealand White Rabbits with venous pouch 
aneurysms treated with pCONus® assisted coil occlusion. 
 
Animal 
No. 
23 22 31 29 27 26 25 38 41 
Aneurysm 
creation 
11.8.11 10.8.11 27.10.11 11.10.11 30.9.11 28.9.11 26.9.11 15.3.12 19.4.12 
Date of 
treatment 
(embolizat
ion) 
13.9.11 13.9.11 05.12.11 06.12.11 06.12.11 06.12.11 3.02.11 15.5.12 15.5.12 
Main 
vessel-Ø 
[mm] 
2,5 2,0 2,5 2 2,5 2,5 2,5 2,6 2,5 
Side 
vessel-Ø 
[mm] 
1,7 0,5 2,1 1,8 2,2 1,5 2,0 2,0 2,0 
Side 
vessel-Ø 
[mm] 
1,8 1,3 2,0 1,9 2,2 1,7 1,8 2,5 2,0 
Height of 
aneurysm 
[mm] 
8,4 8,0 5,0 4,0 7,5 12,0 16,2 12,0 9,0 
Width of 
neurysm 
[mm] 
5,0 4,0 6,0 4,0 5,5 5,0 9,3 6,0 5,0 
Aneurysm 
neck [mm] 
3,5 4,0 5,0 5,0 6,0 4,0 7,9 5,0 4,0 
Deployme
nt and 
detachme
nt of 
pCONus
®
 
Very 
good 
Very 
good 
Very 
good 
Very 
good 
Very 
good 
Very 
good 
Very 
good 
Very 
good 
Very 
good 
Negative 
incidents 
No  No No No No No No No No 
Passing 
through 
pCONus
®
 
Easy  Easy Some 
attempts 
needed 
Easy Easy Some 
attempts 
needed 
Easy Some 
attempts 
needed 
Easy 
pCONus
®
 
migration  
No No No No No 2-3 mm No No No 
Postopera
tive blood 
flow in 
aneurysm 
No, 
100% 
occlusio
n 
No, 
100% 
occlusi
on 
No, 
100% 
occlusion 
No, 
100% 
occlusion 
No, 
100% 
occlusio
n 
No, but 
stasis in 
proximal 
portion 
Flow 
15%, 
occlusio
n 85% 
Remnan
t neck, 
100% 
occlusio
n 
Minimal 
neck 
remnant
, 100% 
occlusio
n 
Postopera
tive blood 
flow in 
vessel 
Yes Yes  Yes Yes: Main 
vessel & 1 
side 
vessel; 
BUT: 1 
side 
vessel 
occluded 
Yes Yes Yes Yes Yes 
Postopera
tive 
negative 
incidents 
No No No No No No No No No 
Variations 
of the 
protocol 
Spasm 
after 
coiling 
No No No No No No No No 
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Animal 
No. 
23 22 31 29 27 26 25 38 41 
Preterm 
death 
14.9.11 
1 day 
after 
treatment 
No No 06.12.11 
same day 
of 
treatment) 
27.12.11 
21 days 
after 
treatment 
19.01.12 
1,5 
months 
after 
treatment 
No No No 
Reason of 
preterm 
death 
Stroke 
in VA 
- - Long 
anesthes
ia 
duration 
Urinary 
Hemorrh
age 
Unknow
n 
- - - 
Post 
embolizati
on follow-
up 
- 16.1.12 16.1.12 - - 16.1.12 4.6.12 No No 
Follow-up 
period 
- 4 
months 
4 months - - 40 days 4 
months 
- - 
MRA 
blood flow 
in vessels 
- Yes Yes - - Yes Yes - - 
Remarks  Fill of 
aneurys
m 
cannot 
be 
evaluate
d by 
MRA 
Fill of 
aneurysm 
cannot be 
evaluated 
by MRA 
  Fill of 
aneurysm 
cannot be 
evaluated 
by MRA 
Fill of 
aneurysm 
cannot be 
evaluated 
by MRA 
  
Final 
follow-up 
date 
- 24.8.12 24.8.12 - - - 24.8.12 24.8.12 31.8.12 
Follow-up 
period 
- 11,5 
months 
8,8 
months 
- - - 6,8 
months 
3,4 
months 
3,6 
months 
DSA 
blood flow 
in vessels 
- Yes  Yes - - - Yes Yes Yes 
Success 
rate 
- 80% 
occlusi
on 
100% 
occlusion 
- - - 100% 
occlusio
n 
100% 
occlusio
n 
100% 
occlusio
n 
Remarks  Re-
coiling 
needed 
due to 
coil 
compact
ation 
     Neck 
remnant 
might 
need re-
coiling 
Little 
neck 
remnant 
might 
need re-
coiling 
 
 
4.7. Histological findings  
Available were 9 specimens fixed in buffered 5% formalin. The investigated 
specimens were taken after 4.3 to 11 months after implantation.  
Conventional histopathology showed an increased vessel diameter due to 
the stenting procedure. Corresponding to the macroscopic aspect, the 
microscopy also revealed no tissue defect and no penetrating wall defects. 
The pCONus
®
 stent filaments showed no or only minor foreign body reaction 
with some macrophages in the interface filament-vessel wall, low neointima 
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formation without significant reduction of the vessel lumen, partial atrophy of 
the muscle layer of the vessel wall. No thrombus formation and no vasculitis 
were encountered (Table 5). 
Cross-sections of the coil area revealed a more complex form of neointima 
formation resulting in a subtotal or total occlusion of the aneurysmatic vessel 
segment.  
In cross-sections of the detachment element again a mild neointima could be 
observed. The interface indicated no or only a mild foreign body reaction. 
In none of the specimens signs of infection and degradation of the vessel 
wall (calcification and atherosclerotic changes) could be observed.  
 
Table 5: Results of the histological evaluation of the test items in 5 venous pouch 
aneurysms after pCONus
®
 assisted coil occlusion 
0 = none; 1 = minimal; 2 = mild; 3 = moderate; 4 = extensive; () = with tendency to 
Sample 
No. 
Inflama-
tory 
infiltate 
Giant 
Cells 
Granulo-
cytes 
Lympho-
cytes 
Macro-
phages 
Plasma 
cells 
Infection Fibrosis Calci-
fication 
Necrosis Degene
-ration 
P0378-
09/12 
0-1 0 0 0 0-1 0 0 1 0 0 0 
P0380-
09/12 
0-1 0 0 0 0-1 0 0 1 0 0 0 
P0384-
09/12 
0-1 0 0 0 0-1 0 0 1 0 0 0 
P0385-
09/12 
0-1 0 0 0 0-1 0 0 1 0 0 0 
P0386-
09/12 
0-1 0 0 0 0-1 0 0 1 0 0 0 
   
 
 
As result, the application of the pCONus
®
 implant in investigated specimens 
provides a tissue compatible stenting procedure covering the inner vessel 
wall of the artery without stenosis and without thrombus formation. 
The biocompatibility and hemocompatibility of the pCONus
®
 implant in these 
cases were considered as excellent with no or only minimal foreign body 
reaction in the interface and with an overall low neointima formation. 
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5. In vitro study 
In order to investigate and quantify the intra-aneurysmal flow modification 
induced by pCONus
®
, different devices, including pCONus
®
, were tested 
during an in vitro experience in Geneva in cooperation with Professor Vitor 
Mendes Pereira, director of the unit of interventional neuroradiology at the 
University Hospital of Geneva. 
In a circulating in vitro closed set-up, a patient specific silicon model 
mimicking a basilar artery bifurcation aneurysm was used to evaluate 
different devices dedicated to endovascular treatment of intracranial 
aneurysms.  
An imaging flow prototype, based on DSA images and optical flow imaging, 
developed by Philips Healthcare, was used to quantify intra-aneurysmal flow 
modification induced by the different devices. 
 
 
5.1. Experimental set-up 
Experimental set-up (Figure 8) consists of a reservoir, which contains a 
mixture of water and glycerin (Water 65% - glycerin 35%) simulating human 
blood, a continuous flow pump, which is modulated by a pulsatile system 
and creates conditions similar to arterial flow, a vascular phantom, and a 
closed circuit.  
 
Figure 8: Experimental set-up for the in vitro testing of the hemodynamic effects of 
pCONus
®
. 
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As vascular phantom, we used a silicon model simulating a wide-necked 
basilar artery bifurcation aneurysm. The size of the aneurysm neck was 4.02 
/ 5.7 mm, the aneurysm height was 6.37 mm and the aneurysm width 7.37 / 
6.43 mm. 
The silicon model (Figure 9 and 10) contains 2 inlets (simulating right and 
left vertebral arteries). One inlet is used for imaging, while the other one is 
used for device implantation. The inlet used for device implantation is 
clipped during imaging to avoid reflux during contrast agent (CA) injection. 
 
Figure 9: Silicon model for the in vitro testing of the hemodynamic effects of 
pCONus
®
. 
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Figure10: Silicon model with a pCONus
®
 device in place. 
                             
 
 
 
5.2. Imaging 
The study was performed on a monoplane flat panel digital subtraction 
angiography (DSA) unit (Allura FD20, Philips Healthcare, Einthoven, The 
Netherlands). 
The angiographic sequences were acquired with a 60 images/second frame 
rate. Flow reduction analysis with MAFA (Mean Aneurysm Flow Amplitude) 
and MAFA ratio calculation was performed with the flow prototype from 
Philips Healthcare. 
Two different CA injection rates (2 and 3 cc/s) were applied for each 
projection view (AP and lateral). Consequently, for each configuration, 2 
angiographic sequences were acquired. 
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5.3. Flow analysis 
The method used to evaluate the flow modification is based on optical flow 
principles applied to DSA sequences and was developed by Philips 
Healthcare. This tool called “angio flow” is still in development. The velocity 
fields could be visualized as vectors or streamlines projected in the line of 
sight of the detector (Figure 11).  
 
Figure 11: “Angio flow” method. (A) Velocity fields without device. (B) Velocity fields 
after device implantation. 
              
 
 
Furthermore, time average velocities can be computed from a region of 
interest covering the aneurysm region from which the mean aneurysm flow 
amplitude (MAFA) before and after stenting could be computed. 
After that, a pre and post implantation ratio R can be calculated as following:  
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5.4. Results 
Pre and post implantation MAFA values were evaluated and the 
corresponding ratio R for each tested device was calculated. These values 
were acquired from the AP view with 2 cc/s injection rate.  
Since flow rate and waveform is not expected to change in experimental 
conditions, pre and post stent sequences could be considered to have been 
acquired in the same flow conditions. 
Consequently R reflects only the flow changes induced by the device.  
 R>1 corresponds to an increase of the intra-aneurysmal flow after 
device implantation.  
 R<1 reflects a reduction of intra-aneurysmal flow. 
 
 
Device MAFA pre/post R 
pCONus® 3.5/3.5 1 
 
 
Based on R, the pCONus
®
 device has, quantitatively, no influence on the 
intraaneurysmal blood flow. 
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6. Clinical experience 
 
6.1 Material and methods 
The results presented below are based on the retrospective analysis of all 
wide-necked intracranial bifurcation aneurysms treated with pCONus
®
 
between February 2012 and April 2014.  
All the procedures included in this series were performed in the “Klinik für 
Nueroradiologie” of the Katharinenhospital Stuttgart by a team of four 
interventional neuroradiologists, and always under the supervision of the 
director of the clinic. 
Procedures were performed on biplane flat panel digital subtraction 
angiography (DSA) units (Axiom Artis, Siemens). 
The endovascular treatment was either proposed to the patient as a result of 
an interdisciplinary discussion or offered on the basis of the a priori 
preference of the patient.  
In elective procedures, all patients had comprehensive consultations prior to 
the procedures, which included an explanation of the disease, all therapeutic 
options, and their respective chances and risks. Microsurgery and 
conservative management were discussed with all elective patients. In 
patients in the acute phase after SAH, endovascular treatment including the 
use of pCONus
®
 was carried out as an emergency measure and whenever 
possible, was explained to the relatives. Written informed consent was 
obtained from all elective patients. 
The decision to use a pCONus
®
 was in all patients based on anatomical 
features of the target aneurysm. In all aneurysms, a wide neck in a vessel 
bifurcation or a diffuse vessel bifurcation enlargement was expected not to 
allow safe and sufficient unassisted coil occlusion. Single vessel stenting 
was always weighted against pCONus
®
 usage. Kissing- or crossing-stents 
was not considered as a preferred alternative to pCONus
®
.  
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6.1.1 Elective cases (Table 6) 
Patients undergoing elective treatment were premedicated at least 1 day 
prior to the treatment with a single loading dose of 500 mg acetylsalicylic 
acid and 600 mg clopidogrel (n = 27) or 180 mg ticagrelor (n = 4). Each 
patient was tested before the endovascular treatment for sufficient inhibition 
of the platelet function with Multiplate
®
 (Roche). Six patients were found to 
be non-responders to clopidogrel and were re-loaded with 30 mg prasugrel 
(n = 2) or 180 mg ticagrelor (n = 4). 
Patient No. 1 had a diagnostic angiography on a Friday with subsequent 
consultation and asked for endovascular treatment, was scheduled for the 
endovascular treatment for the forthcoming Monday and planned for loading, 
but bled prior to the intake of the medication and was therefore treated under 
emergency conditions. 
 
6.1.2 Emergency cases (Table 7) 
Patients with severe SAH underwent ventricular shunting prior to diagnostic 
angiography and eventual endovascular treatment. The decision for an 
endovascular treatment was in all cases based on an interdisciplinary 
discussion between the board-certified neurosurgeon on call and the 
interventional neuroradiologist in charge. Arguments in favor of an 
endovascular approach were poor clinical condition after SAH (Hunt and 
Hess IV-V) or anticipated surgical difficulty (e.g., basilar artery aneurysms).  
As soon as the decision was made to use a pCONus
®
, patients received 
either 600 mg clopidogrel (n = 7) or 180 mg ticagrelor (n = 4) via a 
nasogastric tube. As soon as the pCONus
®
 was deployed, 500 mg 
acetylsalicylic acid was given intravenously. Patient No. 2 suffered severe 
SAH (Fisher IV) due to a ruptured AcomA aneurysm. The poor clinical 
condition (HH V) was in favor of an endovascular treatment and the patient 
was medicated only with 1000 mg acetylsalicylic acid intravenously. 
In the patient No. 17, a local thrombus formation was observed during the 
procedure, which completely resolved after administration of a bolus dose of 
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eptifibatide. After this case, if a patient did not receive a loading dose before 
the treatment, a body weight adapted bolus dose of eptifibatide was applied 
intravenously per protocol. 
After SAH, Patient No. 44 had a diagnostic angiography the day of the 
hospital admission. After angiographic confirmation of a wide-necked basilar 
tip aneurysm and subsequent consultation with the neurosurgeon on call, 
the patient was scheduled for endovascular treatment for the forthcoming 
day. The patient received 500 mg acetylsalicylic acid IV and 180 mg 
ticagrelor per os early in the morning. The treatment was performed 5 hours 
later after confirmation of sufficient inhibition of the platelet function. 
 
Table 6: Premedication in elective cases (n = 37) prior to pCONus
®
 assisted coil 
occlusion of a non-ruptured intracranial aneurysm. 
Premedication n % 
ASA p.o. and clopidogrel p.o. 27 73 
ASA p.o.and ticagrelor p.o. 4 10.8 
ASA p.o., clopidogrel p.o. and ticagrelor p.o. 4 10.8 
ASA p.o., clopidogrel p.o. and prasugrel p.o. 2 5.4 
 
 
Table 7: Premedication in emergency cases (n = 13) prior to pCONus
®
 assisted coil 
occlusion of a ruptured intracranial aneurysm. 
Premedication n % 
ASA i.v. and clopidogrel p.o. 5 38.5 
ASA i.v., ticagrelor p.o. and eptifibatide i.v. 4 30.8 
ASA i.v., clopidogrel p.o. and eptifibatide i.v. 2 15.4 
ASA i.v. and ticagrelor p.o. 1 7.7 
ASA i.v. 1 7.7 
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6.1.3 Procedure  
All patients were treated under general anesthesia using a biplane DSA unit 
(Axiom Artis, Siemens). An intravenous bolus of heparin (5,000 IU) and 500 
mg acetylsalicylic acid were given at the beginning of the procedure. 
Activated clotting time was not routinely measured.  
Via a femoral access, a 6F or 8F guiding catheter was inserted into the 
respective cervical vessel. In a suitable working projection, showing the 
aneurysm neck and the efferent vessels, calibrated measurements were 
used to determine the neck width, the aneurysm width and the aneurysm 
height (Brinjikji et al. 2009).  
The pCONus
®
 size was selected in a way that a complete coverage of the 
aneurysm neck by the pCONus
®
 petals could be expected. A 0.021´´ 
microcatheter (e.g., RapidTransit or Prowler Select Plus, Codman) was 
chosen. The distal end of the pCONus
®
 was deployed in the middle of the 
aneurysm fundus, avoiding any impact to the aneurysm wall. As soon as the 
four petals were fully open, the microcatheter was gently pulled back 
bringing the pCONus
®
 petals more proximal to the neck of the aneurysm. 
Without further movement of the pCONus
®
, the insertion wire of the 
pCONus
®
 was kept in place and the microcatheter was pulled back with 
complete deployment of the shaft of the pCONus
®
. Thereafter a second 
microcatheter was inserted through the shaft of the pCONus
®
 into the 
aneurysm fundus (e.g., Echelon10, ev3/Covidien; Excelsior SL10, Stryker). 
Coil occlusion started with the attempt to create a frame or basket with the 
first coil (e.g., Morpheus coil, Covidien; Framing coil, MicroVention). The 
residual space was filled with long and soft coil (e.g., Hypersoft, 
MicroVention). As soon as the aneurysm fundus was considered completely 
occluded, the coil catheter was withdrawn and the pCONus
®
 was 
electrolytically detached (Figure 12). 
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Figure 12: (A) Unruptured aneurysm of the MCA bifurcation on the left side. (B) The 
distal end of the pCONus
®
 is deployed in the middle of the aneurysm fundus. (C) 
As soon as the four pCONus
®
 petals are fully open, the microcatheter is gently 
pulled back bringing the petals more proximal to the neck of the aneurysm (dotted 
red line). (D) A second microcatheter is inserted through the shaft of the pCONus
®
 
into the aneurysm fundus. (E) Coil-occlusion of the aneurysm (Raymond 1). (F) 
Angiographic follow-up after 3 months showing complete occlusion of the aneurysm 
(Raymond 1). 
 
 
 
 
6.1.4 Postprocedure management 
SAH patients were managed according to widely accepted SOPs. Patients 
with unruptured aneurysms underwent a MRI examination within 48 hours 
after the procedure. If MRI was not possible, a CT scan was performed. 
Angiographic follow-up was scheduled for 3 and 9 months after treatment 
and yearly thereafter. 
Post-procedural medication (Table 8) included a daily lifetime dose of 100 
mg acetylsalicylic acid and 75 mg clopidogrel for three months. 
Nonresponders to clopidogrel or patients directly premedicated with another 
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antiplatelet drug were continued with 10 mg prasugrel (n = 3) or 2x 90 mg 
ticagrelor (n = 11). 
 
 
Table 8: Postmedication after pCONus
®
 assisted coil treatment of an intracranial 
aneurysm (n = 50). 
Postprocedural medication n % 
ASA p.o. & clopidogrel p.o. 36 72 
ASA p.o.& ticagrelor p.o. 11 22 
ASA p.o.& prasugrel p.o. 3 6 
 
 
 
6.1.5 Procedure and postprocedural evaluation 
Patients, aneurysms and procedures were evaluated for: 
 age, gender, history of previous subarachnoid hemorrhage, previous 
treatments of the aneurysms, treatment during the acute phase after 
subarachnoid hemorrhage, and clinical condition at the time of 
treatment according to the mRS (Jenneth et al. 1975) 
 ruptured or unruptured nature of the target aneurysm, long axis, short 
axis, neck size, and location of the aneurysm 
  ability to insert and deploy the pCONus
®
 properly 
  occurrence of aneurysm or target vessel perforation due to the 
pCONus
® 
usage 
  ability to catheterize the aneurysm through the deployed pCONus
®
 
  coil retention inside the aneurysm, as a function of the pCONus
®
, and 
its ability to prevent the inadvertent occlusion of the efferent vessels 
  degree of aneurysm occlusion achieved by coiling (Roy et al. 2001) 
  clinical condition of the patient at discharge. 
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At follow-up patients and aneurysms were clinically and angiographically 
evaluated for: 
 stability of aneurysmal coil occlusion (Raymond et al. 2003) 
 occurrence of intimal hyperplasia inside the stent shaft 
  ability to perform re-coiling of partially reperfused aneurysms as far as 
necessary, in the presence of the previously implanted pCONus
®
 
  clinical condition of the patients during follow-up. 
 
 
6.2 Results 
This retrospective series includes 50 consecutive patients, 25 female (50%) 
and 25 male (50%), and 50 aneurysms treated with pCONus
®
 between 
February 2012 and April 2014. The median age was 59.3 years (range: 25-
76 years). 
The medians and ranges for the aneurysm sizes were: neck width 6.2 mm 
(range: 2.8 – 13.8 mm), fundus width 6.6 mm (range: 3.2 – 15.5 mm), fundus 
height 7.8 mm (range: 2.7 – 17.4 mm). 
The location of the treated aneurysms is summarized in table 9. 39/50 
aneurysms (78%) were located in the anterior circulation, and 11/50 (22%) in 
the posterior circulation. 
Of these 50 aneurysms, 18 were right-sided aneurysms, 10 aneurysms on 
the left side, and 22 aneurysms located in the midline. 
 
Table 9: Location of 50 aneurysms treated with pCONus
®
 assisted coil occlusion. 
Location n % 
Middle cerebral artery 27 54 
AcomA 11 22 
Basilar tip artery bifurcation 9 18 
Anterior cerebral artery (A2-segment) 1 2 
Basilar artery trunk (fenestration) 1 2 
Posterior cerebral artery (P2- segment) 1 2 
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Of the 50 treated aneurysms, 28 (56%) were found incidentally, 13 (26%) 
were detected due to an acute subarachnoid hemorrhage from the treated 
aneurysm, 2 (4%) caused cerebral ischemia (transient ischemic attack - 
TIAs), 1 (2%) was related with blurred vision, and 1 (2%) was detected due 
to a seizure (Table 10). Five out of 50 aneurysms (10%) had been previously 
treated by coiling and showed a major recurrence, which required 
retreatment, 2 of them from previously ruptured aneurysms. 
 
 
Table 10: Symptoms related to 50 intracranial aneurysms treated by pCONus
®
 
assisted coil occlusion. 
Initial symptoms  n % 
No symptoms 33 66 
Acute SAH 13 26 
TIAs 2 4 
Seizure 1 2 
Blurred vision 1 2 
 
 
The treatment of ruptured aneurysms was mostly carried out within the first two 
days after the initial subarachnoid hemorrhage (median 1.7 days, range: 0 - 7 
days). 
The distribution of Hunt and Hess grades at the time of treatment in the 
ruptured aneurysm group (n = 13) is shown in table 11.   
The distribution of Fisher grades at the time of treatment in the ruptured 
aneurysm group (n = 13) is summarized in table 12.   
Thirty-seven aneurysms (74%) were unruptured. The clinical condition of the 
concerning patients was graded according to the modified Rankin Scale (mRS) 
at the time of treatment in the unruptured aneurysm group (n = 37) and is listed 
in table 13. 
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Table 11: Distribution of Hunt and Hess grades after the rupture of 13 intracranial 
aneurysms prior to pCONus
®
 assisted coil occlusion. 
Clinical condition (Hunt & Hess) n % 
HH I 4 30.8 
HH II 3 23.1 
HH III 1 7.7 
HH IV 4 30.8 
HH V 1 7.7 
 
 
Table 12: Amount of intracranial blood, graded according to the Fisher grading 
scale, in 13 ruptured aneurysms that were treated with pCONus
®
 assisted coil 
occlusion. 
Amount of blood on CT scan (Fisher) n % 
Fisher I 0 0 
Fisher II 2 15.4 
Fisher III 2 15.4 
Fisher IV 9 69.2 
 
 
Table 13: Clinical condition of 37 patients with unruptered intracranial aneurysms 
prior to pCONus
®
 assisted coil occlusion. 
modified Rankin Scale (mRS) n % 
mRS 0 32 86.5 
mRS 1 1 2.7 
mRS 2 2 5.4 
mRS 3 1 2.7 
mRS 4 1 2.7 
mRS 5 0 0 
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In 45 out of 50 aneurysms (90%), a single pCONus
®
 alone retained the coils 
inside the aneurysm sac and protected the efferent vessels from occlusion.  
In two patients (4%) two pCONus
®
 deployed in a crossing position were 
necessary to protect the neck region of the aneurysm. For this purpose, a 
special version without distal nylon cross was used to allow telescoping of 
the two devices. Patient No. 26 (Figure 13) presented a large unruptured 
aneurysm of the basilar tip, which incorporated both PCAs and both SCAs 
origins. The aneurysm was directed posteriorly towards the brainstem, with a 
90° angle between the axes of the basilar artery and the aneurysm fundus. 
Patient No. 43 (Figure 14) presented a large unruptured aneurysm of the 
right MCA. The aneurysm neck was asymmetric with the superior trunk of 
the right MCA originating from the aneurysm sac. In both cases, two 
pCONus
®
 were deployed in a crossing position to protect the neck region of 
the aneurysm. 
In three patients (6%) another device aside from pCONus
®
 was necessary to 
prevent the occlusion of the efferent vessels. Patient No. 19 (Figure 15) 
presented a giant partially thrombosed MCA aneurysm. The already 
deployed 12 mm pCONus
®
 was withdrawn because the stabilization of the 
coils appeared insufficient to protect both M2 origins. A 16 mm TriSpan coil 
(Boston Scientific) was inserted and the petals were subsequently 
intermingled with the coil loops. This construct of TriSpan and coils was 
fixated by the pCONus
®
, which was redeployed at the end of the procedure. 
Patient No. 23 (Figure 16) presented a fusiform upper basilar trunk 
aneurysm with both PCAs and SCAs originating from the posterior aspect of 
the aneurysm. A 12 mm pCONus
®
 was inserted into the aneurysm but 
appeared alone insufficient to protect the PCAs and SCAs origins. Two Y-
crossing Solitaires only in both PCAs were expected to incompletely protect 
the SCAs, with difficult control of the coil occlusion of the saccular 
component of the aneurysm. After positioning of the pCONus
®
 petals within 
the lumen of the aneurysm, the left PCA was catheterized and a Solitaire AB 
stent (4/20 mm) was deployed from the left PCA to the basilar artery trunk. 
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After the detachment of this stent, the right PCA was catheterized through 
the shaft of the pCONus
®
 and the first Solitaire AB stent and a second stent 
was deployed from the right PCA to the basilar artery trunk. The resulting 
structure of pCONus
®
 and Y-stenting was stable and allowed for a well- 
controlled coil occlusion of the aneurysm protecting both PCAs and SCAs. 
Patient No. 29 presented a wide-necked AcomA aneurysm. An Enterprise 
Stent was deployed from the left A1 to the left A2-segment in order to protect 
the left ACA. Thereafter, 6 mm pCONus
®
 was inserted into the aneurysm 
from the right side allowing aneurysm occlusion.  
 
Figure 13: Patient No. 26: 25 year old male with a large unruptured basilar tip 
aneurysm. (A) Axial T2WI shows the mass effect to the brainstem. (B) Initial 3D 
reconstruction image of rotational angiogram shows both PCAs and SCAs 
originating from the aneurysm sac. (C) Right vertebral artery injection, lateral view, 
demonstrating the aneurysm. (D) DynaCT showing the crossing pCONus
®
 (2x 15 
mm). (E-F) Right vertebral artery injection, frontal and lateral view, after coiling. 
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Figure 14: Patient No. 43: 68 year old female with a large unruptured MCA-
aneurysm. (A) Right carotid artery injection showing the aneurysm. (B) Roadmap in 
the working projection with a 15 mm pCONus
®
 in place. The superior trunk of the 
MCA is still not protected from coil protrusion (black asterisk). (C) Unsubtracted 
view, after deployment of a second 12 mm pCONus
®
, showing the crossing 
pCONus
®
. (D) Right carotid artery injection after coil occlusion.  
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Figure 15: Patient No. 19: 51 year old male with a large unruptured symptomatic 
(seizure) MCA-aneurysm on the right side. (A) Right carotid artery injection 
showing the aneurysm. (B) Axial T2WI showing a large thrombosed compartment. 
(C) Right carotid artery injection after TriSpan and pCONus
®
 assisted coil 
occlusion. 
 
 
 
 
Figure 16: Patient No. 23: 62 year old female with a large unruptured basilar tip 
aneurysm on the right side. (A) Left vertebral artery injection showing the 
aneurysm, which incorporates the right SCA and both PCAs. (B) Unsubtracted view 
demonstrates the pCONus
®
 (dotted yellow line) and the Y-configuration of the 2 
Solitaire stents (dotted red lines) extending into both posterior cerebral arteries 
from the basilar trunk. (C) Left vertebral artery injection after coiling.  
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Insertion and controlled deployment of pCONus
®
 was possible in all cases 
(100% technical success). Neither access failure nor aneurysm or vessel 
perforation were encountered. Catheterization of the aneurysms through the 
shaft of the deployed pCONus
®
 was possible in all cases and did not cause 
any difficulty. No coil loop protrusion between the petals of the pCONus
®
 
was encountered.  
In only 1 patient (Patient No. 17) a local thrombus formation was observed 
during the procedure, which resolved with a body weight adapted bolus dose 
of Eptifibatide (Figure 17). No another complication was observed during the 
treatment. 
 
 
Figure 17: Patient No. 17: 34 year old female with a ruptured AcomA aneurysm on 
the right side. (A) Right carotid artery injection showing the aneurysm. (B) 
Occlusion of the left ACA after pCONus
®
 assisted coil occlusion (black arrow). (C) 
Complete recanalization after intravenous administration of a body weight adapted 
bolus dose of eptifibatide. 
 
 
 
The 3-points Raymond scale (Raymond et al. 2003) was used to evaluate 
the initial occlusion rate. In 22/50 aneurysms (44%) the occlusion rate was 
graded as class 1 (“complete”), 15/50 aneurysms (30%) were graded as 
class 2 (“neck remnant”) and 13/50 aneurysms (20%) as class 3 (“residual 
fundus perfusion”).  In patients 3 and 18 an early second treatment within 
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the first week was necessary to achieve the occlusion of the aneurysm 
(Table 14).  
 
Table 14: Initial angiographic results in 50 intracranial aneurysms after pCONus
®
 
assisted coil occlusion using the 3-points Raymond scale. 
Initial occlusion rates  n % 
1 – complete 22 44 
2 - neck remnant 15 30 
3 - residual fundus perfusion 13 26 
 
 
Fourty-one patients (82%) underwent either CT (n = 11) or MRI (n = 30) 
examination within a few days after the procedure (Table 15).  
New DWI lesions on MRI occurred in 18/30 patients (60%) and remained 
clinically silent in all except 4 patients. Four out of 50 patients (8%) showed 
transient focal neurological symptoms after the treatment, which resolved 
within one week. No clinically evident complications with permanent 
neurological deficit or death related to the pCONus
®
 deployment or coil 
occlusion occurred. 
Of the 50 patients treated, 5 patients died. Death of patients No. 2, 4 and 20 
was due to a severe SAH; patient No. 11 recovered from her SAH and died 
due to another disease; patient No. 29 died due to concomitant disease 
(Table 16). 
 
 
Table 15: Post-procedure imaging in 50 patients after the pCONus
®
 assisted coil 
occlusion of intracranial aneurysms. 
Imaging n % 
None 9 18 
MRI 30 60 
CT scan 11 22 
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Table 16: Clinical outcome of 50 patients after the treatment of intracranial 
aneurysms with pCONus
®
 assisted coil occlusion. 
Clinical outcome  n % 
New DWI lesions 18 60 
TIAs 4 8 
Permanent neurological deficit related 
to treatment 
0 0 
Previous neurological deficit 5 10 
Death related to the endovascular 
treatment 
0 0 
Death related to the SAH 3 6 
Death related to other diseases 2 4 
 
 
 
Angiographic follow-up was available in 40/50 patients (80%). The first 
follow-up examination was carried out after 104 days (median). The last 
follow-up examination was performed after 276 days (median) (Table 17). 
The first angiographic follow-up showed complete occlusion in 23/40 
aneurysms (57.5%), a neck remnant in 8/40 aneurysms (20%), and an 
aneurysm remnant in 9/40 aneurysms (22.2%).   
Of these 40 aneurysms, the angiographic follow-up showed an improvement 
of the degree of occlusion of at least 1 point on the Raymond grading scale 
in 12 aneurysms (30%), while 23 aneurysms (57.5%) remained unchanged. 
A reduced degree of occlusion was observed in 5 aneurysms (12.5%) (Table 
18). 
Amongst the 9 aneurysms with Raymond 3 at follow-up, five of them were 
deteriorated from a previous aneurysm remnant. Most of them were large or 
giant, partially thrombosed aneurysms after initial partial occlusion. 
 
 
 43 
Table 17: Occlusion rate (Raymond scale) of 40 intracranial aneurysms at 276 days 
(median) after pCONus
®
 assisted coil occlusion. 
Occlusion rates at FU (Raymond-Scale) n % 
1 - complete 23 57.5 
2 - neck remnant 8 20 
3 - residual fundus perfusion 9 22.2 
 
 
 
Table 18: Evolution of the occlusion rate of 40 intracranial aneurysms during the 
angiographic follow-up at 276 days (median) after the pCONus
®
 assisted coil 
occlusion. 
 Raymond 1 (n = 23) Raymond 2 (n = 8) Raymond 3 (n = 9) 
From initial 1 13 1 2 
From initial 2 7 5 2 
From initial 3 3 2 5 
 
 
 
 
At follow-up no intimal hyperplasia inside the pCONus
® 
shaft was observed. 
Coil-migration was observed in one patient, who remained asymptomatic 
(Figure 18). 
Eight out of 9 aneurysms with reperfusion were re-treated by coiling and one 
is still scheduled (Table 19). In these retreated aneurysms, microcatheter 
access to the aneurysm through the implanted pCONus
®
 was again possible 
without any difficulty. The coil retention by the pCONus
® 
was as reliable as 
during the initial procedure (Figure 19).  
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Table 19: Aneurysms with reperfusion. 
Patient No. Location initial RS Time to FU 
(months) 
RS prior / after  
re-treatment 
No. 10 RPCA 1 12 months 3 / 1 
No. 13 RMCA 3 10 months 3 / 3 
No. 16 LMCA 2 4 months 3 / 1 
No. 19 RMCA 3 6 months 3 / 3 
No. 21 RMCA 2 13 months 3 / 2 
No. 23 BA 3 10 months 3 / 2 
No. 25 RMCA 3 10 months 3 / scheduled 
No. 26 BA 3 12 months 3 / 3 
No. 39 AcomA 1 4 months 3 / 2 
 
 
 
 
Figure 18: Patient No. 7: 66 year old male with a reperfusion of a previously 
ruptured AcomA aneurysm. (A) Left carotid artery injection showing the aneurysm 
before intervention. (B) Final run after treatment with pCONus
®
 (Raymond 3). (C) 
Angiographic follow-up after 3 months shows the complete occlusion of the 
aneurysm (Raymond 1) as well as a partial migration of a coil into the A1-segment 
of the left side. Vessel occlusion was not observed. The patient is asymptomatic. 
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Figure 19: Patient No. 21: 62 year old male with an unruptured MCA-aneurysm on 
the right side. (A) Right carotid artery injection showing the final run after treatment 
of the aneurysm with pCONus
®
 (Raymond 2). (B) Angiographic follow-up after 12 
months shows a major reperfusion (Raymond 3). (C) Road-map picture showing 
the access of the microcatheter into the aneurysm through the implanted pCONus
®
. 
(D) Final run after re-coiling (Raymond 2). 
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7. Discussion 
Early experience has shown that unassisted coiling works best in aneurysms 
with a well-defined neck, ideally not wider than 3 mm. 
Coiling of intracranial aneurysms is a useful alternative to surgical clipping. 
Complex wide-necked bifurcation aneurysms, however, present a difficult 
challenge to neurointerventionalists because of their anatomic features. 
 
7.1. 3D Coils 
Three-dimensional coils were an early and a relatively easy-to-use solution 
for all wide neck aneurysms (Cloft et al. 200, Vallée et al. 2005). 3D coils 
alone work best in long aneurysms, but frequently do not find enough 
stability in shallow aneurysms and in those without any neck.  
During pCONus
®
 procedures, the first coil should be a solid 3D coil with an 
appropriate diameter, which might be intermingled with the petals of the 
pCONus
®
. 
 
7.2. “Dual-catheter” technique 
The “dual-catheter” technique is a straightforward and inexpensive strategy 
for the treatment of WNBAs (Baxter et al. 1998). A first catheter is used to 
deploy a framing coil (e.g., a 3D coil). This coil will, however, not be 
detached immediately. Subsequent coils will be inserted via a second 
microcatheter. A known risk of the “dual catheter technique” is related to the 
phenomenon that the first coil may not entirely protect the vessel bifurcation. 
While the first coil and subsequent coils remain controllable until they are 
detached, displacement of already detached coils by subsequent coils 
remains a serious issue. Good results with the dual or multiple microcatheter 
technique were reported by Kwon et al. but it is not perfect for WNBAs 
whenever the framing coil(s) provide insufficient neck protection.  
A better protection of the aneurysm neck/parent vessel region might be 
provided by pCONus
®
 but also with this device the use of small and short 
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coils adjacent to the aneurysm neck carries a potencial risk of coil 
displacement into the parent vessel. 
 
7.3. “Balloon-remodeling” technique 
The “balloon-remodeling” technique was initially advocated for sidewall 
aneurysms (Moret et al. 1997). The development of more flexible and 
atraumatic compliant balloon catheters allows today for the simultaneous 
use of multiples balloons (Baldi et al. 2003, Lubicz et al. 2004, Arat et al. 
2005). However, risks of this technique are well known. Catheterization of 
the efferent vessels of a bifurcation can be very difficult and the presence of 
two or three catheters in the parent vessel unavoidably causes a temporary 
interruption of the cerebral blood flow and may cause hemodynamic 
compromises and/or thromboembolic events. The coverage of the aneurysm 
neck, once the balloons are inflated, is solid, but overinflation may cause 
vessel dissection or even rupture, and the risk of aneurysm rupture due to 
coil-induced pressure on the aneurysm wall may be increased (Spiotta et al 
2001). Besides, the balloon coverage is temporary. If the coils, introduced 
under balloon protection, do not stabilize each other, balloon deflation may 
be followed by collapse of the coils out of the aneurysm into the parent 
vessel.  
In the available literature, positive reports for balloon remodeling can be 
found (Lubicz et al. 2004, Spiotta et al. 2011, Gallas et al. 2005, Layton et al. 
2007). Serious warnings were also brought forward. Sluzewski et al. 
(Sluzewski et al. 2006) reported on the basis of 71 procedures a morbidity 
and mortality for balloon remodeled aneurysm coiling of 14%, without 
improved stabilization of the coil occlusion during the subsequent course. In 
a small series of 43 aneurysms reported by Cronqvist et al. (Cronqvist et al. 
2005), 5 major complications occurred among 11 balloon remodeling 
procedures. Pierot et al. (Pierot et al. 2012) recently published a review in 
favor of balloon remodeling. However in other studies, follow-up occlusion 
rates post stenting are consistently better than after balloon remodeling 
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(Chalouhi et al. 2013).  
In our practice, we use balloon remodeling for proximal sidewall aneurysms 
(e.g., in cavernous and paraophthalmic location). We consider the use of 
multiple balloons as risky in general and often not justified.  
In comparison with balloon remodeling in WNBAs, the use of pCONus
®
 is 
easier and more controllable, without interruption of the blood flow and 
without the need to catheterize the efferent vessels. The need for dual 
medical antiaggregation for pCONus
®
 is certainly a drawback, especially in 
ruptured aneurysms. 
 
7.4. “Stent-remodeling” technique 
Neuroform (Stryker), Enterprise (Codman), Leo+ (Balt), Solitaire 
(ev3/Covidien) and LVIS (MicroVention) are self-expanding stents for the 
treatment of WNBAs. These stents show significantly different features, 
including stent design, cell size, radial force and thrombogenicity (Krischek 
et al. 2011). Placing a stent over an aneurysm orifice may cause a neck 
diameter reduction (Adel et al. 2010). Stenting also improves and stabilizes 
the occlusion rate of wide neck aneurysms after coil treatment (Lubicz et al. 
2009, Piotin et al. 2010). Stent assisted coiling can, however, be technically 
demanding (Henkes et al. 2004) and may result in severe complications.  
In a retrospective analysis of a large series with 216 stented (predominantly 
with Neuroform) and coiled aneurysms, Piotin et al. (Piotin et al. 2010) found 
rates for procedure related permanent neurological morbidity and mortality of 
7.4% and 6%, respectively. Stent deployment in a vessel bifurcation will 
straighten the vessels. This effect is not the same for all stents. Closed-cell 
stents straighten more than open-cell stents (Gao et al. 2012). In general 
this phenomenon may improve the hemodynamic situation in bifurcation 
aneurysms. In their literature survey on stent-assisted aneurysm coiling 
Shapiro et al. evaluated data from 39 articles with 1517 patients (Shapiro et 
al. 2012). They found a 9% rate of stent-related technical issues, 4% failure 
of stent deployment, 19% overall procedure complication rate, and 2.1% 
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periprocedural mortality. 
The bridging of a vessel bifurcation by a single stent may provide insufficient 
coil retention. A more robust vessel reconstruction can be achieved, if stents 
are deployed in both branching vessels (“Y-stenting”). These stent 
reconstructions are mostly to be followed by coil occlusion of the aneurysm.  
Sani et al. report on the Y-stenting of a MCA aneurysm using Neuroform 
(Sani et al. 2005). Chow et al. and Thorell et al., as well as, Perez-Arjona et 
al. and Lozen et al. focused on Y-stenting and coiling for the treatment of 
basilar bifurcation aneurysms (Chow et al. 2004, Thorell et al. 2005, Cho et 
al. 2007, Perez-Arjona et al. 2004, Lozen et al. 2009). Rohde et al. used 
Enterprise stents for this procedure (Rohde et al. 2010).  
For the combined use of different stents (e.g., Neuroform and Enterprise), 
the term “hybrid Y-configured stenting” was coined (Akgul et al. 2011). 
Alurkar et al. and Lee et al. used Y-stenting (Neuroform or Enterprise) for 
ruptured aneurysms in the acute phase after SAH without complications 
(Alurkar et al. 2012, Lee et al. 2012).  
The inherent risks of Y-stenting become obvious from the retrospective 
analysis of a small series of 19 patients who underwent Y-stent assisted 
coiling of their aneurysms (Spiotta et al. 2011). The incidence of 
complications at the initial treatment was 31.6%. Delayed thromboembolic 
complications were encountered in 10.5%. In a recently published 
multicenter trial, Fargen et al. reported on 45 (mostly basilar apex) 
aneurysms treated by Y-stenting and coiling with a rate of 84% of complete 
occlusion or neck remnant and an 11% procedural complication rate (Fargen 
et al. 2013).  
Cekirge et al. were the first to emphasize the hemodynamic effect of Y-
stenting with Enterprise (Cekirge et al. 2011). They observed reduced 
perfusion and final thrombosis of WNBAs after Y-stenting with Enterprise 
without coiling. One of the reasons why stents such as Enterprise with 
relatively large cells become hemodynamically active once they are used in 
crossing fashion is the compression and deformation of the stents at their 
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intersection (Zhao et al. 2012). If there is no jailed catheter inside the 
aneurysm, catheterization for coiling through crossing Enterprise stents can 
be very difficult.  
If the mutual compression of the crossing stents could be avoided, one stent 
can be completely deployed in one of the two efferent vessels and the 
second one is then deployed in a way that its proximal end is immediately 
adjacent to but not crossing the first stent (“non overlapping Y-configuration 
stenting”) (Cho et al. 2012).  
For Y-stenting, hemodynamic effects are related to the metal construct in the 
parent artery and the alteration of the geometry of the efferent vessels. The 
formation of neointima over crossing stents appears at least unlikely. 
If an aneurysm has afferent and efferent vessels on both sides (e.g., AcomA 
aneurysms with bilaterally patent A1 segments), two stents can be deployed 
without direct contact, protecting the bifurcation on either side (“parallel 
stenting”, “opposite L configuration”).  
An even denser coverage of the aneurysm neck is achieved, if the stents 
cross each other (“X-stenting”). Saatci et al. report a series of 5 patients with 
ACA aneurysms, treated with X-crossing stent assisted coiling (Saatci et al. 
2011). Stents were deployed from one A1 segment to the contralateral A2, 
crossing each other in front of the aneurysm orifice. They used the “jailed 
catheter” technique for the coil catheter and, despite loose initial packing, 
found complete occlusion at 6 months follow-up DSA without in-stent 
stenoses. Patients received dual medical platelet inhibition for 6 months. 
Similar procedures with X-crossing stents were described by other authors 
(Lazzaro et al. 2011, Zele  k et al. 2011). With Y- or X-crossing stents, 
significantly more stent material is placed in the blood stream than a 
pCONus
®
 deployment (Sychra et al. 2011) (Figure 20). However, the 
advantage of permanently modifying the angulation of the vessel bifurcation 
observed after stenting, cannot be expected from a pCONus
®
 treatment. 
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Figure 20: Comparison between pCONus
®
 and Y-crossing stent. pCONus
®
 
provides significantly less device material in bifurcation and especially in outflowing 
vessels.        
 
 
7.5. TriSpan neck-bridging device 
The TriSpan neck-bridging device (Boston Scientific) was made of 3 nitinol 
loops (“petals”). These loops were coated with polyxylylene. Both ends of each 
petal were fixed to a central platinum coil (“umbilicus”, “stem”). This “umbilicus” 
was attached to a stainless steel insertion wire. Detachment of the TriSpan from 
the wire was possible using the GDC method of direct current induced rapid 
corrosion. The compressed device was accepted by a 0.021 inch inner diameter 
microcatheter. It was positioned just beyond the level of the neck of the target 
aneurysm. Upon withdrawal of the microcatheter, the petals of the TriSpan 
opened similar to a flower blossom. The device was kept in this position but 
change or correction of the position and even withdrawal was possible. Once 
the device was properly placed, a second microcatheter was inserted into the 
aneurysm fundus between the TriSpan petals and used for subsequent coil 
occlusion. The electrolytical detachment of the device was mostly kept as the 
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last step of the procedure.  
Experimental (Turk et al. 2002, Raymond et al. 2002) and early clinical results 
(Chan et al. 2004) were promising. Raymond et al. treated 25 aneurysm 
patients, and TriSpan deployment failed in only 2. Complete occlusion was 
achieved in 3/25, a neck remnant was found in 13/25 and a residual aneurysm 
perfusion in 7/25. Two patients had device related ischemic complications. DSA 
follow-up in 16 patients showed only 4 completely obliterated aneurysms and 12 
residual or recurrent aneurysm perfusions (Raymond et al. 2001). De 
Keukeleire et al. reported on 14 patients treated with this device with a 
complication rate of 37.5%, associated with a low primary complete occlusion 
rate (12.5%) and a high recurrence rate. A specific concern was 
thromboembolic events, presumably related to the large foreign body surface in 
conjunction with inconsistent medical antiaggregation (De Keukeleire et al. 
2008).  
The issues with TriSpan were multifold. Physician inexperience, lack of 
adequate training and proctoring contributed to the known issues. The 
aneurysms TriSpan was made and used for were anatomically difficult lesions. 
The procedures frequently gained an unusual complexity (Henkes et al. 2004). 
The proper deployment of the TriSpan was critical in aneurysms with a 
significant asymmetry or in the case of a steep angle between the longitudinal 
axis of the parent vessel and the aneurysm fundus. The TriSpan, once 
detached, had no further fixation. It was therefore necessary to either stabilize 
the device at the aneurysm wall or to intermingle coils and TriSpan petals in 
order to create a self-stabilizing conglomerate. The producing company (Boston 
Scientific) never gained FDA approval for this device, which certainly was useful 
but was too difficult for widespread acceptance. In 2007, the production of 
TriSpan was terminated. 
pCONus® adopts functional features of the TriSpan through its distal petals. 
Similar to TriSpan, pCONus® can be repositioned and/or withdrawn. The 
positions of the four pCONus® petals (instead of 3 TriSpan loops) are, however, 
more stable due to their connection with the shaft. While TriSpan procedures 
were mostly carried out without medical antiaggregation, pCONus® should only 
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be implanted under dual antiaggregation. Aneurysm asymmetry is of less 
concern. Due to the firm connection between distal petals and proximal shaft, 
the device shows a tendency to center itself in asymmetric aneurysms. Similar 
to the behavior of TriSpan, the ability of pCONus® to retain small coils (i.e., ≤2 
mm diameter) inside an aneurysm is poor. The coil occlusion of an aneurysm 
after pCONus® deployment should be started with at least one 3D coil and 
should be completed with long and soft coils with a diameter of no less than 3 
mm – just as previously with TriSpan. In the case of reperfusion of an aneurysm 
and endovascular retreatment, a previously detached TriSpan did not provide 
stability for further coils. Using another TriSpan sometimes solved this. In 
aneurysms treated with pCONus® assisted coiling, it can be expected that the 
petals of the first pCONus® remain in the same position, and again prevent coils 
from displacement in the parent vessel(s). 
 
7.6. “Waffle cone” technique 
The term “waffle cone” technique refers to a situation in which a self-expanding 
stent is deployed with its distal end inside an aneurysm instead of bridging the 
aneurysm neck.  
Neuroform (Horowitz et al. 2006, Yang et al. 2008, Huang et al. 2009, Xu et al. 
2011), Solitaire AB (Synchra et al. 2011, Park et al. 2012), Leo+ (Yang et al. 
2010) and Enterprise (Gruber et al. 2010) have been used for this purpose.  
The “waffle cone” stent deployment may be combined with a dual catheter 
technique (Park et al. 2012, Gordhan et al. 2010) or with a ⎫-configuration 
stenting (Cho et al. 2011). In this case, one stent is deployed in the accessible 
efferent vessel and a second crossing stent is deployed inside the aneurysm. 
Conventional stents may have features, which are far from ideal for this 
purpose. Enterprise for instance has a smaller cell size and less radial force 
than Solitaire and pCONus® (Krischek et al. 2011). Stent migration has been 
observed with Enterprise if deployed in the parent vessel (Kelly et al. 2008). The 
risk of migration is even higher if the distal end of the Enterprise stent is placed 
inside an aneurysm, with an axial outward force exerted by the coils. The 
intended use of pCONus® is similar to the “waffle cone” deployment of the 
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above-mentioned stents, with the difference that pCONus® is made and 
optimized for this purpose.  
The “waffle cone” and pCONus® technique is superior to crossing stents since 
less material is deployed inside the blood stream (Synchra et al. 2011). The 
difference between “waffle cone” deployment of conventional stents and the 
pCONus® is related to the distal embodiment of the devices. The Enterprise 
stent has flared distal ends. The Solitaire AB has 4 sharp ends with radiopaque 
markers. Both are potentially more traumatic to the wall of the aneurysm than 
the wings of the pCONus®. In any case a wide neck aneurysm considered for 
“waffle cone” stenting or pCONus® reconstruction should have a longitudinal 
fundus diameter of ≥ 4mm (Huang et al. 2009). Even more important, however, 
is the fact that pCONus® exerts a more stable coil retention inside the aneurysm 
than conventional self- expanding stents. Horowitz et al. reported on 6 WNBAs 
treated with “waffle cone” technique using Neuroform stents (Horowitz et al. 
2006). Sychra et al. used Solitaire AB in 6 wide neck bifurcation aneurysms for 
“waffle-cone” technique (Sychra et al. 2011). The procedure was successful in 
all patients, but the occlusion rate was limited to Raymond class 2 in all 6 
aneurysms. Four patients underwent angiographic follow-up, all showing 
asymptomatic reperfusion that required retreatment. This retreatment was 
possible without other remodeling devices since the “waffle cone” Solitaire 
stents were still in the proper positions. The antiaggregation with Clopidogrel 
was stopped after 8 weeks without thromboembolic complications.  
It has been suggested that “waffle cone” deployment and pCONus® device can 
worsen the hemodynamic situation by directing the blood stream towards the 
aneurysm instead of blood flow diverting away from it (Gao et al. 2012, Sychra 
et al. 2011, Huang et al. 2009). At this moment this is an unjustified concern, 
which is not supported by experimental or clinical data. Furthermore the results 
of our in vitro study showed that the intra aneurismal flow remains unchanged 
after pCONus® implantation. Liu et al. report good results from 10 aneurysm 
patients who underwent a “waffle cone” stent implantation to assist coil 
occlusion (Liu et al. 2012). The initial rate of occlusion was adequate in all 
aneurysms and, as in our series. Angiographic follow-up showed a stable 
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degree or improvement of occlusion in most aneurysms. An impared occlusion 
at follow-up was mainly observed in large and giant partially thrombosed 
aneurysms. None of the aneurysms treated in the acute phase after SAH 
rebled. 
 
7.7. Intraaneurysmal flow diversion 
The concept of intraaneurysmal flow diversion has prompted the development 
of two similar devices: Woven EndoBridge (WEB) (Sequent Medical) and Luna 
(nFocus/Covidien). Both devices are spherical implants, made from braided 
nitinol wires. They are introduced into the aneurysm fundus via a microcatheter 
and deployed by a slow withdraw of this microcatheter. Due to the shape-
memory properties of the nitinol wires, a self-expansion of the device takes 
place. The structure of the WEB is denser than that of LUNA. Therefore more 
hemodynamic effect is expected from the WEB device. Both devices can be 
either pulled back into the microcatheter or detached from their insertion wire. 
The WEB was evaluated in an animal model, which confirmed the intended 
function of the device (Ding et al. 2011). Promising initial clinical results with 
WEB have been published (Klisch et al. 2011, Pierot et al. 2012). 
Intraaneurysmal flow diversion or disruption will most likely play a role in the 
future practice of the endovascular treatment of WNBAs. There are, however, 
certain apparent issues with this device. The device itself is more rigid than 
conventional stents or flow diverters. This can cause friction-related difficulties 
during the insertion. Sizing of these devices is critical. Therefore, a variety of 
different sizes and shapes have to be available in order to match all possible 
anatomic situations. Both devices are less suitable for very large aneurysms 
and those with irregular shape. As it is mostly the case with the mechanism of 
flow diversion, the exclusion of an aneurysm from blood circulation is less 
predictable than after dense coil occlusion. Little is known about the mid- and 
long-term results with this device and aneurysm regrowth after WEB occlusion 
has been reported (Wallner et al. 2012). In the case of recurrent or persistent 
perfusion of an aneurysm treated with these devices, re-treatment can be 
difficult. 
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7.8. Pulsar Vascular Aneurysm Neck Reconstruction Device 
The “Pulsar Vascular Aneurysm Neck Reconstruction Device” (PVANRD), 
previously named “PulseRider Neck Reconstruction Device” (Pulsar Vascular) 
is a bifurcation stent that can be implanted in intracranial vessel bifurcations in 
front of wide neck aneurysms. The device is used outside the aneurysm sac 
and should support coil occlusion. The implant is attached to wires that provide 
stability in the vessel. Turk et al. (Turk et al. 2012) report a good performance of 
the device in an animal model. Clinical data is not yet available. The main issue 
of this device is the control of orientation and position in the parent vessel 
bifurcation and in relation to the aneurysm neck. Safety and efficacy of this 
device are currently not known, but it has CE mark. 
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8. Summary 
This study reports the in vitro study of the pCONus
®
 device, its use in 9 New 
Zealand rabbits as well as the retrospective evaluation of 50 intracranial 
aneurysms treated with pCONus
®
 between February 2012 and April 2014 in 
the Department of Neuroradiology of the Katharinenhospital in Stuttgart.  
In our experience, pCONus
®
 significantly facilitates the endovascular coil 
occlusion of bifurcation aneurysms. Its use is safe and well controllable. 
pCONus
®
 combines functional features of extrasaccular implants (for 
example, self-expanding stents) and intrasaccular implants (for example, 
TriSpan). The specific advantages of this new device are related to the facts 
that pCONus
®
 does not cause an interruption of the blood flow in the target 
vessel, is deployed without catheterizing the efferent vessels and can be 
withdrawn or corrected after complete deployment if necessary.  
pCONus
®
 provides a tissue compatible stenting procedure covering the inner 
vessel wall of the artery without stenosis and without thrombus formation 
and has excellent biocompatibility and haemocompatibility with no or only 
minimal foreign body reaction in the interface and with an overall low 
neointima formation. 
pCONus
®
 provides a stable and permanent scaffold for the coils inside the 
aneurysm and has, quantitatively, no influence on the aneurysm flow. 
The device is certainly not suitable for all aneurysms. We expect limitations if 
the aneurysm fundus is < 5 mm and if the relation depth/width is >2. For 
aneurysms with a neck diameter > 15 mm, the 15 mm pCONus
®
 may not 
provide sufficient coil retention. The additional use of a second pCONus
®
 or 
of a device with a function similar to TriSpan may add safety under these 
rare circumstances.  
Recurrent perfusion of an aneurysm fundus after coil occlusion may be an 
indication for microsurgical clipping. Following pCONus
®
 implantation and if 
the position of the device is unchanged, the aneurysm neck will remain 
bridged by the struts of the pCONus
®
, which will most likely interfere with the 
proper closure of an aneurysm clip. 
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